<DOC>
	<DOCNO>NCT02404155</DOCNO>
	<brief_summary>Clozapine ( CLZ ) effective antipsychotic treatment-refractory schizophrenia ( SZ ) . Despite overwhelming evidence superior efficacy , CLZ infrequently prescribe US , considerably low rate estimate prevalence treatment-resistant SZ , especially African-Americans ( AA ) . Recent evidence suggest low Absolute Neutrophil Counts ( ANC ) , either baseline treatment significant barrier CLZ use AA patient US , guideline mandate CLZ discontinuation ANC drop 1500 cells/mm3 . The investigator group find discontinuation CLZ AA patient twice European-American ( EA ) patient ( N~400 ; 42 % vs.19 % , P=0.041 ) initiation rate 50 % low . In Statewide study ( N=1875 ) , investigator report discontinuation frequently due neutropenia AA sample , though AA develop agranulocytosis ( 8 case EA ) . Benign Ethnic Neutropenia ( BEN ) people African ancestry , include AAs , identifies group ( 50 % AA ) low ANCs increase risk agranulocytosis infection . Low baseline in-treatment fluctuation require CLZ discontinuation current prescribing guideline common CLZ-treated person BEN . In investigator recent pilot study N=12 AA patient BEN , treatment safely successfully continue CLZ despite low baseline ANC ( outside current guideline ) . Recent evidence implicates polymorphism Duffy Antigen Receptor Chemokine ( DARC ) gene pathophysiology BEN . In homozygote ( FY-/- ) DARC null allele , mean within-subject neutrophil count reduce , result sporadic ANC &lt; 1500 cells/mm3 10-15 % people allele . In population study , FY-/- genotype find 0.01 % EAs , 99.3 % sub-Saharan Africans ( SSA ) , 68 % AAs . Further , missense DARC mutation report interact DARC FY-/- determine low WBC AAs . Normal pattern week-to-week fluctuation ANC level individual African ancestry BEN DARC null genotype know , publish research examine variation ANC African ancestry CLZ-treated SZ patient BEN DARC null genotype ( FY-/- ) . Such data also lack individual BEN without DARC null genotype . Conducting research generate genetic marker safety data could use expand access CLZ AA patient otherwise eligible receive superior treatment option .</brief_summary>
	<brief_title>Biomarker Safety Study Clozapine Patients With Benign Ethnic Neutropenia ( BEN )</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>Inclusion Criteria Eligible recommend clozapine treatment ( e.g . treatment resistant schizophrenia , schizoaffective disorder , bipolar disorder , psychotic disorder , delusional disorder , hostility , document rationale ) Male Female African Ancestry ( African , AfricanAmerican AfricanCaribbean ) . This population make majority study . However , case BEN individual Middle Eastern , Caucasian , ethnicity . The investigator accept patient may unknown African ancestry genotyping important . Age : 18 64 year . History low absolute neutrophil count ( ANC &lt; 2500 cells/mm3 past 24 month ) Documented ability sign inform consent . This score ≥10/12 ESC . Effective birth control child bear potential Exclusion Criteria DSMIV diagnosis Mental Retardation Pregnancy lactation History myeloproliferative disorder Uncontrolled seizure disorder History paralytic ileus History clozapineinduced ANC &lt; 700 mm3 Systemic Lupus Erythematosus , Multiple Sclerosis , Hashimoto 's Thyroiditis , Sjogren 's Syndrome , Grave 's Disease* Medical condition whose pathology treatment would likely alter presentation treatment schizophrenia significantly increase risk associate propose protocol . Medical condition affect patient 's ability mount immune response Current bacterial viral infection* Sickle cell anemia Positive bacteria urine culture* Temperature &gt; 37.5 º Celsius , 99.5 º Fahrenheit* Current treat untreated cancer* Documented nutritional deficiency ( Beriberi , Pellagra , Rickets , Scurvy , Keshan Disease ) *</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>